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INTRODUCTION
The Western Pacific Region (WPR) of the World Health Organization (WHO) is spread
over a vast area extending from China, Japan and the Republic of Korea in the North to
Australia and New Zealand in the South, from China, Malaysia and Singapore in the West to
Cook Islands and French Polynesia in the East. Covering nearly one-third of the world's
population, the WPR is perhaps the most culturally and socially diverse of the six regions of
WHO.The Region embraces some of the world's least developed countries as well as its
most rapidly growing economies. Geographically, most of the countries in the Region are
located in tropical or subtropical zone.
There is relatively little information avalilable on dengue fever. The presence of
dengue fever (DF) or DF-like illness was knownprior to World War E in countries and
areas in the WPR such as South China, Indo-China Peninsula, Philippines, Fiji, New
Caledonia and some other Pacific Islands. It spreads widely during the war throughout the
Pacific area and appears to have occurred almost everywhere that Ae. aegypti or another
suitable Stegomyia vector was present.
The first patient identified with dengue haemorrhagic fever (DHF) was recognized in
Manila, Philippines in 1954. Since then, the number of patients with DF/DHF has steadily in-
creased. In 1962, dengue virus infection has spread rapidly not only in Asia and the Pacific
Islands, but also in Africa and Central and South America. In the WPR, 28 to 35 countries
and areas experienced DF/DHF outbreaks during the past two decades. DF/DHF is now
recognized as one of the major public health problems in most of the countries in the WPR.
Japanese Encephalitis (JE) is a serious public health problem with significant mortality
and severe sequelae for childiren and old people in Asia. It has been under control in Japan
and the Republic of Korea where better agricultural practices, vector control and immuniza-
tion have been applied. Immunization with locally-produced JE vaccine has been carried out
in China. Local vaccine production in Viet Nam has been supported by WHOand technology
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on JE vaccine production has been transferred from Japan. Although the existence of JE in
countries in the Indo-China peninsula is suspected, accurate epidemiological record is not
available due to shortage of laboratory diagnostic facility and lack of experienced personnel
in hospitals and laboratories.
DF/DHF EPIDEMIOLOGICAL SITUATION IN THE WESTERN PACIFIC REGION SINCE THE 1940s
China
An epidemic of febrile illness, suspected to be DF, occurred along the southeast cost of
China including Shanghai City. However, outbreaks of this DF-like illness were not
reported from 1950 to 1977. Since 1978, epidemics of DF/DHF have been reported and it is
nowendemic in South China.
Japan
DF outbreak was experienced in Japan in 1942 and the epidemics occurred until 1945
in the main southern part of Japan including Osaka, Kobe and Nagasaki. Data on the actual
number of patients was unclear but it was estimated to be around 200,000 to 1-2 million
and in Osaka alone, one-third to one-half of the population was ill of the disease in 1944
(Sabin, 1948). The dengue epidemic in Japan from 1942 to 1945 was one of the greatest
epidemics ever recorded in a temperate zone and was unique in that the disease disappeared
after 1945 and no endemic cases have been reported in the country since. By retrospective
study, dengue virus type 1 (DEN- 1) infection was suspected during that time in Japan (Hot-
ta S., 1965).
Cambodia/Lao People 's Democratic Republic/Viet Nam
DF was known to be widely present in the Indo-China Peninsula of WPR such as
Cambodia, Lao People's Democratic Republic (Lao PDP) and Viet Nam.However, relatively
little information is available due to poor health system.
In Cambodia, the presence of DHF was confirmed in 1963. However, no annual data
had been received in WHO because national reporting system was initiated only in 1980. It is
nowendemic in Cambodia.
In Lao PDR, endemicity was first confirmed in 1984 and a major outbreak was record-
ed in 1985, endemicity has been reported since.
In Viet Nam, an outbreak of severe haemorrhagic disease in children occurred in Hanoi
in 1958 and it was suspected as DHF outbreak. In 1960, a DHF-like illness occurred in
South Viet Nam and a major DF outbreak was reported in North Viet Nam. Since 1975, ma-
jor outbreaks have been reported annually from north and south Viet Nam.
124
M alays ia/Singapo re
In Malaysia, the virus has been widespread following an outbreak in Kuala Lumpur in
1954. DHF was first reported in Penang, Malaysia in 1962 and the virus was detected as
dengue virus type 2 (DEN-2). An endemic has been reported since 1973.
In Singapore, DF became endemic following the first reported outbreak of the disease
in 1960 (Singapore, 1989) and is now considered endemic.
Philippines
Before World War II , DF endemic was already known in the Philippines. In 1953, new
febrile and serious illness among children in Manila and Luzon islands was reported and nam-
ed "Philippines Haemorrhagic Fever" (Quintos, FN. et. al., 1954). Isolation of virus and
serological examination were made from these haemorrhagic patients including fatal cases
and were determined to be DF. Following the study in the Philippines, an illness named
Thailand Haemorrhagic Fever was also confirmed as an identical disease with the Philippines
Haemorrhagic Fever associated with dengue infection (Hammon, W. McD et. al., 1960). It
was given the name dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). After
the initial recognition of DHF in Manila, cases continued to appear each year with con-
siderable year-to-year variation in numbers.
The South Pacific countries
In the South Pacific area, DF endemic was known in the 1940s in Fiji, New Caledonia,
Papua New Guinea, Samoa and Solomon Islands. However, the disease was virtually absent
for 20 years after the war. Dengue viruses became active again in the Pacific region in 1964
when a dengue virus type 3 (DEN-3) outbreaks occurred in Tahiti, French Polynesia, and
recurred in 1969. Early in 1971, DEN-2 epidemics occurred in Fiji, French Polynesia,
Kiribati, and Papua New Guinea. Following these outbreaks, DF occurred in Nauru, New
Caledonia, Samoa and Vanuatu in 1972. In Tonga, a new relatively low-intensity epidemic
occurred in 1974. DF is now endemic in the South Pacific countries and areas.
PRESENT DF/DHF EPIDEMIOLOGICAL SITUATION IN THE WESTERN PACIFIC REGION
The presence of DF or DF-like illness was known prior to World War I in countries
and areas in the Western Pacific Region. It spread widely during the war throughout the
Pacific area, but was inactive for some time. In the 1960s, dengue virus infections have
spread again rapidly in the Region. This has been attributed to rapid urbanization of coun-
tries in the Region and increase in the number of travellers associated with the progress in
travel mode particularly the use of aircraft which might be an important factor in spreading
the vector mosquito and the virus from one country to another. During the period
1975-1979, 19 countries/areas in the WPR reported existence of DF/DHF. It was 22 in
1980-1984, 26 in 1985-1989, and 19 countries/areas out of the 35 Member States were
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reported from 1990 up to October 1993. A total of 28 out of the 35 countries and areas in
the Region namely, American Samoa, Australia, Cambodia, China, Cook Islands, Fiji, French
Polynesia, Guam, Kiribati, Lao PDR, Malaysia, Marshall Islands, Nauru, New Caledonia,
New Zealand, Niue, Palau, Papua New Guinea, Philippines, Samoa, Solomon Islands,
Tokelau, Tonga, Vanuatu, Viet Nam and Willis and Futuna Islands, experienced DF/DHF
outbreaks during the past two decades. There has been no report from Brunei, Hong Kong,
Macao, Mariana Islands, Micronesia and the Republic of Korea. Japan experienced a DF out-
break in the 1940s, but none was reported since 1945, as mentioned above.
China
DF/DHF had not been reported in China from 1950 to 1977. An epidemic of DF due to
dengue virus type 4 (DEN-4) occurred in Foshan City, Guangdong Province in 1978. A
more localized outbreak of mild DF due to DEN- 1 occurred in Zhongshan Country, Foshan
Prefecture, Guangdong Province in 1979, followed by a major outbreak caused by DEN-3
on Hainan Island in 1980. Annual reports have not been received regularly from the Govern-
ment of China. However, a major epidemic seems to have occurred in 1983 with 85,293
cases and 3,032 deaths. In 1985-1986, DEN-2 infected DF occurred also in Hainan Island.
Majority of patients in China were adolescents and adults. Multiple peripheral paralysis such
as facial palsy was observed as unusual clinical manifestation in the report (Qiu FX, et. al.,
1993). In 1989, 37,886 cases with 807 deaths was reported. In 1990, it was reduced to 376
cases with no deaths reported. However, it increased again to 46,680 cases with unclear
number of deaths.
Cambodia/Lao People 's Democratic Republic/Viet Nam
In Cambodia, DF/DHF has been ranked as one of the ten leading causes of hospitaliza-
tion and deaths. Statistics from the National Centre for Hygiene and Epidemiology (CNHE)
in Phnom Penh show that the number of cases has steadily increased since 1980. In 1990,
there was a major outbreak with 7259 and 331 deaths. Fatality cases has been very high in
Cambodia ranging from 3.6% to 12.4% compared with 0.3% to 1.0% in Thailand over the
same period. Prevention and control measure of DF/DHF are still inadequate in Cambodia.
Total number of DHF in this country in 1992 was approximately 4800 cases with 172 deaths.
This is lower than in 1990, the year of the biggest outbreak in this country, but is higher
than in 1991.
In Lao PDR, a big epidemic of DF/DHF was experienced during the period
1985-1988. WPRO Data Bank recorded 365 cases with 43 deaths in 1986 and 1212 cases
with 27 deaths in 1988. However in 1987 and 1989, 9699 cases with 295 deaths (T.
Fukunaga, 1990) and 5263 cases with 91 deaths (A. Igarashi, 1991) was reported. Incidence
report has been submitted irregularly to WHO. Unreported cases may have existed because
of poor reporting system in this country.
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Viet Nam reported the highest number of cases in the Region. High prevalence of
DF/DHF was observed for the first time in South Viet Nam in 1960 and in North Viet Nam
in 1969. The biggest outbreak occurred in 1987 with a total of 354,517 cases with 1566
deaths. However, there has been no major outbreak over the past few years.
The reporting system on communicable diseases including DF/DHF in both Lao PDR
and Cambodia is poor. However, it is strongly suspected that most cases and significant
epidemics on DF/DHF existed in these countries due to similar situation with neighbouring
countries such as Viet Nam and Thailand.
Malays ia/Singapo re
In Malaysia and Singapore, there had been outbreaks in 1965-1969 and 1970-1974,
respectively. Case number had been reduced when a nationwide DF/DHF control programme
was implemented. However in the 1980s, the case number has gradually increased and the
present number is now higher than the last major outbreak in both countries.
Ph ilipp ines
The outbreak in 1986 was the largest in the Philippines. The number of cases was 9384
with 250 deaths. Since then, the number had been decreasing gradually. However, it has in-
creased again since 1990. The number of cases in 1990 was 4836 with 363 deaths. Incidence
and mortality rates from 1958 to 1989 is indicated in Table 1. It is clear that incidence rates
became higher during these 7 years. However, mortality rate was constantly at 0.2%-0.5%
in this country. Mean incidence rate in all ages is 3.0%. The highest mortality rate is also in-
dicated under 1 year old with 2.5% per 100,000 population and second rank is 1-4 years old
age group with 1.0%. Mortality rate in the age group older than 5 years old is from 0% to
0.6% and the mean mortality rate in all ages is 0.4%.
South Pacific countries
After a virtual absence of DF/DHF in South Pacific for 20 years, it has become
endemic since the 1970s. The biggest outbreak was observed in French Polynesia in 1979
and another one followed in 1989, which was considered as second biggest in the South
Pacific. In 1964, the dominant type of dengue virus was DEN-3. However, DEN-2 was
dominant in 1971-1972, DEN-1 in 1975-1978 and DEN-4 was isolated in 1979-1980.
DEN-1 and DEN-3 are dominant in recent years.
Two groups are present during outbreak peaks in the South Pacific. One group has
epidemic peaks in 1975-1979 and/or 1985- 1989 such as French Polynesia, New Caledonia,
Western Samoa and Wallis and Futuna. The other group's peak was in 1980-1984 such as
Cook Islands, Nauru, Niue and Tonga. The case number had been increasing since 1990 in
Cook Islands, Fiji and Tonga, but decreased in 1993.
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CLINICAL FEATURES OF JAPANESE ENCEPHALITIS
Japanese encephalitis (JE), a mosquito-transmitted flavivirus (formerly of the ar-
bovirus group B), is closely related to St. Louis encephalitis in the New World, to West Nile
virus in Africa, and to Murray Valley encephalitis virus in Australia/New Guinea. Outbreaks
occur during summerand affect all age groups, but with the highest mortality rate in the
younger age groups, pre-teenagers, and the elderly. Pigs have been incriminated as an im-
portant vertebrate amplifying host for JE virus and several Culicine species seem to play a
significant role as a vector mosquito during the outbreak of JE. Not all individuals bitten by
infected mosquitoes develop the disease. All those who have been infected, however, develop
antibodies to JE virus. The ratio of overt disease to inapparent infections varies from 1:20 to
1:1,000.
The incubation period in man, following mosquito bite, may range from 5 to 15 days.
The course of the disease can be conveniently divided into three stages as follows:
(1) Prodromal stage-The onset of the illness is usually acute and is heralded by fever.
The essential features of this stage are general malaise, headache and fever often ac-
companied by rigors. Headache is usually severe and nausea/vomiting are common.
(2) Acute encephalitic stage-The predominant features of this stage are continuous
fever, nuchal rigidity, focal CNS signs, convulsions and altered sensorial progressing in
many cases to coma.
(3) Late stage-Convalescence is usually show. Patients may recover motor functions
but cognitive abnormalities remain. The most commonly observed sequelae in patients
are mental impairment, severe emotional instability, personality changes, paralysis
either of the upper or lower motor neuron type. Aphasia and organic psychoses are less
common.
During outbreaks, the diagnosis of the disease becomes difficult as other illnesses con-
tinute to occur. Febrile convulsions in children may accompany manyillnesses. Parasitic and
bacterial meningitides may be indistinguishable. Tuberculosis meningitis is commonly seen in
children, but has more indolent onset. Cerebral malaria may be confused with encephalitis,
particularly in regions when many persons have positive blood smears for malaria. Rabies,
poliomyelitis, measles, mumpsand herpes viruses may cause encephalitides. West Nile virus
maycause encephalitis. Reye's syndrome and encephalitis caused by toxic substances should
also be considered in the differential diagnosis.
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PRESENT JE EPIDEMIOLOGICAL SITUATION IN THE WPR
The disease incidence appears to be subsiding in China, Japan and the Republic of
Korea but at the same time it has been increasing and spreading over some countries in Asia
such as Bangladesh, Burma, India, Nepal, Thailand and Viet Nam. The reasons for these
changes are not clear but the following factors may be involved:
(1) changes in agriculture system such as adoption of rice cultivation, use of pesticides
and establishment of large modern pig farms;
(2) changes in socio-economic status involving a shift to rice cultivation from dry land
crops and promotion of pig breeding as a food source;
(3) climates, including effects of temperature and rainfall;
(4) effects of immunization;
(5) possible role of additional potential amplifying hosts other than pigs; and
(6) the wide variety of mosquito species in Southeast Asia and their different vectorial
capacity.
Cambodia
There has been no report on JE in Cambodia. However, it is strongly suspected that
JE is endemic in the country because neighbouring countries such as Viet Nam, Lao PDR
and Thailand have reported several JE cases and the agriculture system and pig breeding in
these countries, which are important factors for vector mosquito breeding, are similar with
Cambodia.
China
JE is prevalent in all provinces, except in Xinjiang, Shanghai, and Xizang (Tibet).
Large-scale JE vaccine production was established in the 1960s in China. Fifty million
doses of inactivated JE vaccine are produced annually and another 2 million doses of live JE
vaccine are produced. However, 20 000 to 40 000 patients diagnosed as "acute encephalitis
syndrome" are reported each year and mortality rate is more than 10%.
Japan
Since 1967, JE has been an uncommondisease in Japan and around 10 sporadic cases
are reported every year. It has become a disease of the older age groups. A gradual decrease
of immunity in older persons has been taking place creating a potential for future disease out-
breaks.
Republic of Korea
Prior to 1969, JE occurred annually in the Republic of Korea with more than 1,000
cases and case fatality rate of over 40%. Reported cases were from 0 to few cases since
1984. JE immunization has been used widely in the country.
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Lao PDR
There are no official reports of JE cases and even acute encephalitis syndrome in Lao
PDR, because JE is not included in the 16 priority communicable diseases being reported to
the National Institute of Hygiene and Epidemiology. However, 13 cases clinically diagnosed
as viral encephalomyelitis in Vientiane in 1989- 1991 were confirmed as JE by identification
of IgM antibody in CSF and sera, determined in the AFRIMS (Armed Forces Research In-
stitute for Medical Science) in Thailand. Three of the 13 patients died (fatality rate was
23.1%). JICA/WHO programme on JE prevention and control started in 1992. A virological
laboratory has been set up to determine JE and DF/DHF. A clinical training course was held
in August 1993 in Vientiane.
Ph ilippines
Only sporadic cases were reported in the madical journals. Low priority is given to JE
as one of the public health problems in the country.
Viet Nam "
The propagation of JE is most serious especially in North Viet Nam. Annual morbidity
and mortality decreased gradually because no major epidemic occurred. However, approx-
imately 1,000 cases and 10% of case fatality rate were reported during the recent years. The
National Institute of Hygiene and Epidemiology in Hanoi started a pilot production of inac-
tivated JE vaccine and the Government has decided to produce it on large-scale basis.
WHOhas supported the activity on JE vaccine production in Viet Nam and technology has
been transferred from BIKEN Kanonji Institute, Research Foundation for Microbial Diseases
in Osaka University, Japan, and the Institute of Tropical Medicine, Nagasaki University, the
WHOCollaborating Centre for Reference and Research on Tropical Virus Diseases, Japan.
Approximately 78,000 doses of JE vaccine were produced in the last ten months and field
trials has been started.
DISCUSSION
DF/DHF is recognized as one of the major public health problems in most of the coun-
tries in Region such as China, Philippines, Malaysia, Singapore and the countries in the In-
do-China Peninsula. In the South Pacific, several countries have experienced DF/DHF out-
breaks since 1970 and are nowconsidered endemic. There is no cure or practical use of the
vaccine against the disease at present. Disease surveillance and virological diagnosis must be
improved so that endemic countries in the Region will have more accurate information and
proper case management. However, shortage of trained personnel, facility and equipment for
clinical and virological diagnosis is a big obstacle in most of the DF/DHF endemic countries
in the Region.
In May 1993, the Forty-Sixth World Health Assembly of WHO called for global ac-
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tion to control DF/DHF and urges Member States to strengthen national and local program-
mes for prevention and control of DF/DHF.
In 1994-1995, WPRO supported study programmes of fellows from China and Viet
Namto train in Indonesia on DF virological study; and from Laos and Viet Nam to train in
Thailand on case management. WHOconsultants visited Viet Nam and Laos to undertake
consultancy on laboratory examination. The DHF Control Committee has been organized by
the Ministry of Health in Cambodia and their activities have been strongly supported by
WHOand other international agencies. Printing of manuals on DF case management in local
language was supported in Cambodia and Laos. Training courses on epidemiology, laboratory
examination and case management were held in Viet Nam, Cambodia and Laos. The
South-East Regional Office has published every year a Dengue Newsletter to exchange and
share information on DF/DHF situation in both SEAR and WPR.
Vector control of DF/DHF has been under the Vector-Borne Control (VBC) Unit in
WPRO. Emergency supply of mosquito nets and insecticides were provided to the South
Pacific. A manual on vector control of dengue virus will be published by WPRO.
DF/DHF prevention and control should be among WPRO's top priorities and advance
implementation activities should commence.
Japanese encephalitis (JE) is under control in Japan and the Republic of Korea.
However, it is still serious in China and Viet Nam because of its high mortality rate in
children and irreversible severe sequelae such as motor nervous paralysis and mental retarda-
tion.
Immunization with locally-produced JE vaccine (both live and inactivated) has been
carried out in China. In Viet Nam, particularly in the northern part, JE is one of the serious
communicable diseases. Local vaccine production in Viet Nam has been supported by WHO
and technology on JE vaccine production with mousebrain culture system has been transfer-
red from Japan, but still in the laboratory-scale. However, 78,000 doses of inactivated JE
vaccines were produced from June 1992 to March 1994 and 40,000 children have been im-
munized with locally-produced vaccine. The quality of the vaccine met the Japanese vaccine
standard by quality control examinations in Japan. The programme on local JE vaccine pro-
duction in Viet Nam should be continuously supported.
The reporting system of JE and acute encephalitis syndrome, which is only a clinical
diagnosis, is poor in the Indo-China countries/areas, although suspected to be endemic in
these places. Shortage of laboratory diagnostic facilities and lack of experienced personnel in
hospitals and laboratories are causes of poor reporting system. Activities on virological
diagnosis have been encouraged and supported.
